Decision aid in selecting an antidepressive chemotherapy for the very elderly;Aide décisionnelle au choix d'une chimiothérapie antidépressive au grand âge

Revue de Geriatrie

Volumn 21, Issue 8, 1996, Pages 543-554

  Maniere, D ^a   Pfitzenmeyer, P ^a   Clement, J P ^b  

^a Ctr Gerontologique de Champmaillot   (France)

^b NONE   (France)

Author keywords

Antidepressant drugs; Depression; Elderly

Indexed keywords

AMITRIPTYLINE; AMOXAPINE; ANTIDEPRESSANT AGENT; CITALOPRAM; CLOMIPRAMINE; DESIPRAMINE; DOSULEPIN; DOXEPIN; FLUOXETINE; FLUVOXAMINE MALEATE; IMIPRAMINE; IPRONIAZID; MAPROTILINE; MEDIFOXAMINE; MIANSERIN; MOTIVAL; NIALAMIDE; NOCLAMINE; PAROXETINE; TIANEPTINE; TOLOXATONE; TRIMIPRAMINE; UNCLASSIFIED DRUG; VILOXAZINE;

AGED; AGING; ARTICLE; DEPRESSION; DRUG EFFICACY; DRUG SAFETY; FRANCE; GERIATRIC PATIENT; HUMAN; PRESCRIPTION;

EID: 0030426773     PISSN: 03977927     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (105)

1. VAN MARWIJK H , HOEKSEMA H L , HERMANS J., KAPTEIN A-A , MULDER J.D. Prevalence of depressive symptoms and depressive disorder in primary care patients over 65 years of age Fam Pract , 1994, 11, 80-84
2. CASEY D.A Depression in the elderly South Med J . 1994, 87 559-563.
3. BURWILL P W HALL W D . STAMPFER H.G., EMMERSON J P. The prognosis of depression in old ags. Br J Psychiatry, 1991; 158 64-71.
4. BONIN-GUILLAUME S., CLEMENT J P . CHASSAIN A.P . LEGER J.M. Evaluation psychométrique de la dépression du sujet âgé quels instruments? Quelles perspectives d'avenir? Encéphale 1995, XXI. 25-34.
5. BRESSLER R , KATZ M D Drug therapy for genatric depression Drugs Aging 1993, 3, 195-219
6. ANSTEY K , BRODATY H, Antidepressants and the elderly: double-blind trials 1987-1992 Int. J Genat Psychiat 1995, 10 265-279
7. BLAZER D , WILLIAMS C D Epidemiology of dysphoria and depression in an elderly population Am J Psychiatry. 1980, 137, 439-444.
8. GURLAND B , CROSS P Epidemiology of psychopathology in old age Psychiatr Clin North Am , 1982, 5 11-25
9. ROVNER B W GERMAN P S . BRANT E. Depression and mortality in nursing home JAMA 1991, 265: 993-996.
10. ABRAMSR C TERESIJ A., BUTIND N Depression in nursing home residents Clin Geriatr Med,. 1992, 8: 309-322
11. GEORGOTAS A , Mc CUE R E , FRIEDMAN E., COOPER T B Response of depressive symptoms to nortriptyline, phenelzine and placebo Birt J Psychiatr . 1987, 151 102-106
12. KATZ I R . SIMPSON G M . CURLIK S M PARMELEE P.A MUHLY C Pharmacological treatment of major depression for elderly patients in residential care settings J Clin Psychiat, 1990. 5: 41-47
13. COHN J B VARGA L . LYFORD A A two-center double-blind study of Nomifensine Imipramine and placebo in genatnc outpatients. J Clin Psychiat . 1984 45 68-72
14. GERNER R , ESTABROOK W . STELLER J. et JARVIK L Treatment of geriatric depression with Trazodone Imipramine and placebo a double blind study J Clin Psychiat . 1980 41 216-220
15. MERIDETH C H FEIGHNER J P HENDRICKSON G A double-blind comparative evaluation of the efficacity and safety of Nomifensine. Imipramine and placebo in depressed genatric outpatient. J Clin. Psychiat . 1984 45 73-77
16. NYTH A L GOTTFRIES C G LYBY K et al A controlled multicenter clinical study of citalopram and placebo in elderly depressed patients with and without concomitant dementia Acta Psychiatr Scand 1992, 86 138-145
17. Boston Collaborative Drug Surveillance Program Adverse reactions to tricyclic antidepressant drugs Lancet 1977- 1 529-531
18. BLAKE A J MORGAN K . BINDALL M J et al Falls by elderly people at home prevalence and associated factors Age Ageing 1988 17 365-372
19. GERSON S.C., PLOTKIN D A. and JARVIK L.F Antidepressant drug studies, 1964 to 1986: empirical evidence for aging patients. J Clin. Psychopharmacol. 1988: 8: 311-322.
20. DESSAIN E C., SCHATZBERG A.F., WOODS B.T. et al. Maprotiline treatment in depression. a perspective on seizures. Arch. Gen Psychiat , 1986: 43: 86-90.
21. PRESKORN S.H., FAST G.A. Tricyclic antidepressant-induced seizures and plasma drug concentration. J. Clin Psychiat, 1992, 53: 160-162.
22. BURROWS G.D., VOHRA J , HUNT D et al. Cardiac effects of different tricyclic antidepressant drugs. Br. J Psychiat. 1976; 529: 335-341
23. HALPER J.P., MANN J.J. Cardiovascular effects of antidepressant medications. Br. J. Psychiat., 1988; 153 (suppl.3): 87-98.
24. DICTIONNAIRE VIDAL, 1996 Ed. Editions du Vidal - Paris.
25. HALE A.S. New antidepressants: use in high-risk patients. J. Clin. Psychiat., 1993; 54 (suppl.8): 61-70.
26. DIQUET B., LACOMBLEZ L., PUECH A Pharmacocinétique des médicaments psychotropes Editions Techniques Encycl. Med. Chir. (Paris-France), Psychiatrie, 37860 A40, 6p.
27. MAITRE L Antidépresseurs et Lithium In: Pharmacologie. Des concepts fondamentaux aux applications thérapeutiques. M. SORDEREL et al Ed. Frison-Roche (Paris) - Slatkine (Genève) -1992.
28. NORMAN T. R. Pharmacokinetic aspects of antidepressant treatment in the elderly Prog. Neuro-Psychopharmacol. & Biol. Psychiatr., 1993, 17: 329-344.
29. MOLTKE (VON) L.L., GREEENBLATT D.J , SHADER R.I. Clinical pharmacokinetics of antidepresssants in the elderly. Clin. Pharmacokinet. 1993; 24: 141-160.
30. RICHELSON E. Antidepressants: pharmacology and clinical use In KARASU, ed. Treatment of psychiatric disorders, Vol.3, American Psychiatric Association, Washington D C., 1989, pp 1773-1787
31. HOLLISTER L , GSERNANSKY J. G. Clinical pharmacology of psychotherapeutic drugs. 3rd edition, New-York: Churchill Livingstone, 1990, pp 59-96.
32. ELKIN L, SHEA T., WATKINS J.T. et al. National Institute of Mental Health Treatment of Depression Collaborative Research Program general effectiveness of treatments. Arch. Gen. Psychiat, 1989; 46. 971-982.
33. VOLZ H.P , MOLLER H.J. Antidepressant drug therapy in the elderly A critical review of the controlled clinical trials conducted since 1980. Pharmacopsychiatry, 1994; 27: 93-100
34. DEWAN M.J., HUSZONEK J., Koss M. et al. The use of antidepressants in the elderly :1986 and 1989 J Geriat. Psych. Neurol., 1992, 5: 40-44.
35. CHUA T.P., VONG S K. Paroxetine and hyponatremia. Br. J Clin. Pract. 1994; 48. 49
36. CREWSJ R., POTTSN.L., SCHRBBERJ. et al. Hyponatremia in a patient treated with Sertraline Am J Psychiat, 1993, 150: 1564.
37. JEANDEL C., JOUANNY P., HERBEUVAL F. et al. Hyponatrémie sévère par syndrome de sécrétion inappropriée d 'hormone antidiurétique induit par la Fluoxétine. Thérapie 1993; 48 487-489.
38. FLJNTA. J., CROSBY J., GENIK J. L. Recurrent hyponatremia associated with Fluoxetine and Paroxetine. Am. J Psychiat, 1996, 153. 134
39. TENHOLTW .L , KLAASSENCH. L., SCHRUVERG. et al. Severe hyponatremia possibly due to inappropriate diuretic hormone secretion, during use of antidepressant Fluoxetine Ned. Tijaschr. Geneeshd 1994: 138- 1181-1183
40. BRYMERC., WINOGRADC H Fluoxetine in elderly patients: is there cause for concern J Am. Ger. Soc 1992; 40: 902-905.
41. FICHTNER C G . BRAUN B.G. Hyperphagia and weight loss during Fluoxetine treatment. Ann Pharmacother 1994; 28: 1350-1352
42. DEBUS J.R . RUSH A J . HIMMEL C et al. Fluoxetine versus Trazodone in the treatment of outpatients with major depression. J. Clin. Psychiatry 1988, 49 422-426.
43. ROUBILLE R., MOULSMA A ., FERRY M . Problèmes posés par I 'administration des formes orales médicamenteuses chez les patients sous nutrition entérate. Liste des médicaments àne pas pulvériser. Rev. Gériatr. 1991. 16: 399-408
44. MARTIN P., MASSOL J., CHIGNON J.M., PUECH A.J. Effect of benzodiazepines on reversal by tricyclics or serotonin uptake blokers of depressive-like behaviour in rodents. Fundam Clin. Pharmacol 1990; 4: 428-429
45. POLLACKM, H., ROSENBAUM J F. Management of antidepressant-induced side effects: a practical guide for clinician. J. Clin. Psychiat., 1987; 48: 3-8.
46. ASBERG M., TRASKMAN L., THOREN P. S-HIAA in the cerebrospinalfluid a biochemical suicide predictor? Arch. Gen. Psychiat., 1976, 33: 1193-1197
47. BANKI C.M. Correlation of anxiety and related symptoms with cerebrospinal fluid Shydroxyindolacetic acid in depressed women. J. Neural. Transm., 1977, 41: 135-143.
48. BANKI C.M , ARATO M. Amine metabolites, neuroendocrine findings, and personality dimension as correlates of suicidal behaviour. Psychjat. Res., 1983; 10, 253-261
49. VAN PRAAG H.M., KAHN R , ASMS G.M et al. Beyond nosology in biological psychiatry. S-HT disturbances in mood, agression and anxiety disorders. In: BRILEY M., FILLION G., eds. New Concept in depression London: Mc Millian Press. 1988, pp. 96-119.
50. VAN PRAAG H.M., ASNIS G.M ., BROWN S L., KORN M. L. Monoamine and abnormal behaviour: a multi-dimensional perspective. Br. J. Psychiat., 1990, 157, 723-734.
51. DALERY J., BOUHASSIRA M , KRESS J.P. et al. Dépressions majeures "agitées-anxieuses" versus "émoussées-raienties" effets différentiels de la Ruoxétine Encéphale, 1995, 21: 217-225.
52. JOUVENT R., BOUVARD M., LEBOYER M. et al. L'approche transnosographique de I 'effet des psychotropes: I 'exemple du déficit émotionnel (ou émoussement affectif). Encéphale, 1987, 13: 317.
53. GARRE J.B. La notion de dépression atypique. Encéphale. 1992; 18: 721-725
54. ROY M., SENON J.L., JALLOT G.H. Interrogations sur la notion de dépression atypique In: Masson Ed Comptes-rendus du congrès de neurologie et de psychiatrie de langue française Paris, 1983, pp. 158-164
55. LIEBOWITZ M.R., KLEIN D.F. Hysteroid dysphoria. Psychiatr Clin. North Am., 1979; 2: 555-575
56. RUSH A.J DMS IV mood disorders In . RAGAGNI G. et al , Eds . Biological psychiatry, vol. 1, Amsterdam : Excerpta Medica, 1991.
57. LIEBOWITZ M.R . QUINKIN F M , STEWART J.W et al. Phenelzine vs Imipramine in atypical depression: a preliminary report Arch Gen. Psychiat., 1984, 41, 669-677.
58. LIEBOWITZ M R., QUITKIN F M., STEWART J.W. et al. Antidepressant specificity in atypical depression Arch. Gen. Psychiat. 1988; 45: 129-137.
59. SALZMAN C , Monoamine oxidase inhibitors and atypical antidepressants. Clin Genatr. Med, 1992; 8: 335-348.
60. SOVNER R. D . The clinical characteristics and treatment of Atypical Depression. J Clin Psychiat., 1981: 42. 285-289.
61. AMADO I. Effets cognitifs des antidépresseurs en chronique Encéphale, 1995; 21 (suppl. 1): 15-18.
62. AMADO-BOCCARA I., GOUGOULIS N , POIRIER-UTTRE M.F. et al. Incidence des antidépresseurs sur les fonctions cognitiues. Revue de la littérature Encéphale. 1994; 20- 65-77
63. HANTOUCHE E , PIAU A., LOO H Quels antidépresseurs pour le dément et ie sujet agé? In. Maloine Ed., Démence et dépression. Paris: Fondation Nationale de Gérontologie, 1989: pp 122-145.
64. CLEMENT J.P , LEGER J.M Place des antidépresseurs dans la prise en charge des sujets déments. Encéphale, 1995; 21. Supp. IV: 43-19.
65. HEBENSTREIT G F . BAUMHACK U., CHAN-PALAY V. et al. The treatment of depression in geriatric depressed and demented patients by Moclobemide. results from an international multicenter double-blind controlled trial. In: 5th Congres of IPA abstracts 1991 31.
66. PETURSSON H. The use of Moclobemide in elderly depressed patients: a double-blind placebocontrolled study from the international study group of Moclobemide in geriatric depression. Vienna. Third International 8ymposium. 1992. march 29-31.
67. WESNES K., ANAND R . LORSCHEID T. Potential of Moclobemide to improve cerebral insufficiency identified using scopolamine model of aging and dementia Acta Psychiatr. Scand . 1990. 80 (suppl. 360) 71-72.
68. SCHONE W , LUDWIG M, A double-blind study of Paroxetine compared with Fluoxetine in geriatric patients with major depression J. Clin. Psychopharmacol , 1993, 13 (suppl. 2). 34S-39S
69. ROWLAND N, ANTELMAN S M , KOCAN D, Differences among serotoninergic anorectics in a cross-tolerance paradigm: do they all act on serotoninergic systems? Eur. J. Pharmacol. 1982: 81: 57-66.
70. KELSEY M C , GROSSBERG G.T. Serotonin specific reuptake inhibitors and their role in inducing weight loss. Facts Res Geront 1995:9 374-376.
71. . NOLAN L . O'MALLEY K. Adverse effects of antidepressants in the elderly. Drugs Aging, 1992; 2 450-458
72. RICHELSON E. Pharmacology of antidepressants Characteristics of the ideal drug. Mayo Clinic Proc . 1994, 69, 1069-1081
73. ARANOW R B , HUDSON J.I , POPE H G Jr et al Elevated antidepressant plasma levels after addition of Fluoxetine. Am J Psychiat , 1989, 146, 911-913
74. GOODNICK P.J Influence of Fluoxeurae on plasma levels of Desipramine. Letter to the editor Am. J Psychiat., 1989 146 552
75. PRESKORN S.H . BEBER J.H., FAUL J.C., HIRSCHFELD RMA Serious adverse effects of combining Fluoxetine and tricyclic antidepressants. Letter to the editor Am. J Psychiat. 1990: 147 552
76. MEYERS B.S Geriatric delusional depression. Clin Genatr Med., 1992: 8. 299-308
77. SHIFANO F, GARBIN A., RENESTO V et al A double-blind comparison of miansenn and maprotiline in depressed medically ill elderly people Acta Psychiatr Scand., 1990, 81 289-294
78. GWIRTSMAN H.E , AHLES S , HALARIS A , DE MET E., ANN-HILL M. Therapeutic superiority of maprotiline versus doxepine in geriatric depression. J Clin. Psychiatry. 1983, 44 449-453
79. SIEGFRIED K , O'CONNOLLY M, Cognitive and psychomotor effects of different antidepressants in the treatment of old age depression. Int Clin. Psychopharmacol, 1986: 1: 231-243.
80. ALTAMURA A.C. MAURI M C . COLACURCIO F et al. Trazodone in late life depressive states: a double-blind multicenter study versus amitriptyline and mianserin Psychopharmacol 1988 95: S34-S36
81. ALTAMURA A.C MAURI M.D RUDAS M. et al Clinical activity and tolerabibty of trazodone. mianserin and amitriptyline in elderly subjects with major depression a controlled multicenter trial Clin. Neuropharmacol , 1989: 12 S25-S33
82. DE VANNA M , KUMMER J., AGNOLI A . GENTILI P , LORIZIO A , ANAND R Moclobemide compared with second-generation antidepressants in elderly people Acta Psychiatr Scand 1990, 360, 64-66.
83. TILLER J , MAGUIRE K . DAVIES B. A sequential double-blind controlled study of moclobemide and mianserin in elderly depressed patients Int J Geriatr Psychiat. 1990, 5 199-204
84. PHANJOO A L . WLNNACOTT S HODGSON A Double-blind comparative multicentre study offtuvoxamine and mianserin in the treatment of major depressive episode tn elderly people Acta Psychiatr Scand 1991. 83 476-479
85. EKLUND K DUNBAR G C . PINDER R M . STEFFENSEN K Mianserin in the treatment of elderly depressed patients Acta Psychiatr 8cand., 1985. (suppl 320): 54-59
86. SCARDIGU G., JANS G. Comparative double-blind study on efficacity and side effects of Trazodone, nomifensine, mianserin in elderly patients in: Costa E . Racagni G . Eds Typical and atypical antidepressants clinical practice. New-York Raven Press. 1982. pp 229-236.
87. LA PIA S GIORGIO R , CIRIELLO A. et al Evaluation of the efficacity. tolerabuity and therapeutic profil of fluoxetine versus mianserin in the treatment of depressive disorders in the elderly Curr Therapeut. Res . 1992: 52: 847-858
88. DORMAN T Sleep and paroxetine. a comparison with mianserin in elderly depressed patients, Int. Clin Psychopharmacol., 1992: 6 (suppl) 53-58
89. DE LEO D , CEOLA A , MAGNI G Viloxazine against placebo in a double-blind study in depressed elderly patients. Curr Therapeut Res . 1984: 36. 239-244
90. NUGENT D. A double-blind study of viloxazine (Vivalan) and amitriptyline in depressed genatrics patients Clin Trials J . 1979: 16: 13-16.
91. FEIGHNER J P., BOYER W.F., HENDRICKSON G.G., PAMBAKIAN R.A . DOROSKI V.S A controlled trial of adinazolam versus desipramine in geriatric depression. Int J Clin. Psychopharmacol., 1990: 5 227-232.
92. WAKELIN J.S. Fluvoxamine in the treatment of the older depressed patient, double-blind, placebocontrolled data Int J Clin Psychopharmacol . 1986. 1 221-230.
93. HOSTMAELINGEN N J., ASSKILT O., AUSTAD S.G. et al. Primary care treatment of depression in the erderly: a double-blind, multi-centre study of flupenthixol (Fluanxol) and sustained-release amtririptyline. Curr. Med Res Opin . 1989. II 593-599
94. COHN C.K , SHRIVASTAVA R , MENDELS J., VINCE H., CLARKE A Double-blind, multicenter comparison of sertraline and amitriptyline in elderly depressed patients. J Clin. Psychiat., 1990; 51: 28-33.
95. HUTCHINSON D.R , TONG S , MOON A.L et al. Paroxetine in the treatment of elderly depressed patients in general practice: a double-blind comparison with amitriptyline. Int. Clin. Psychopharmacol . 1992: 6 (suppl.4) 43-51
96. ATHER S A., ANKIER S I , MIDDLETON R S W A double -blind evaluation of trazodone in the treatment of depression in the elderly. Brit J. Clin. Practice. 1985, 39 192-199.
97. GUILLIBERT E., PELICIER Y . ARCHAMBAULT J.C et al. A double-blind multicentre study of paroxetine versus clomipramine in depressed elderly patients Acta Psychsatr 8cand., 1989. 80 (suppl. 350) 132-134.
98. DUNNER D L . COHN J B . WALSHE T. et al Two combined, multicenter double-blind studies of paroxetine and doxepin in geriatric patients with major depression J. Clin. Psychiat . 1992. 53 (suppl.) 57-60
99. FEIGHNER J.P., COHN J B Double-blind comparative trials offluoxetine and doxspine in geriatric patients with major depressive disorder J Clin. Psychiat 1985, 46 20-25.
100. FAIRBURN A.F , GEORGE K . DORMAN T Lofepramine versus dothiepin in the treatment ot depression in elderly patients Brit. J. Clin Pract. 1989, 43, 55-60
101. RAHMAN M K AKTHAR M.J. SAVLA N.C . KELLET J H . ASHFORD J J, A double-blind, randomised comparison offluvoxamine with dothiepin in the treatment of depression in elderly patients Brit J Clin Pract. 1991 45 255-258.
102. ALTAMURA A C . PERCUDANI M . GUERCETTI G., INVERNIZZI G Efficacity and tolerability of fluoxetine in the elderly a double-blind study versus amitripiyline Int J Clin Psychopharmacol , 1989, 4 103-106
103. TOLLEFSON G D HOLMAN S L. Analysis of the Hamilton Depression Rating Scale factors from a double-blind, placebo-controlled trial offluoxetine in geriatric major depression Int J Clin Psychopharmacol 1993. 8 253-259
104. ROBERT P DARCOURT G Action antidêpressive de la Mėdifoxamine (Cledial®) dans une population de plus de 65 ans In: Masson Ed Comptesrendus du Congrès de Psychiatrie et Neurologie de Langue Française MONTREAL. 1990. pp 587-593
105. RAFFAITIN F Efficacity and acceptibility of traneptine in the elderly a review of clinical trans Eur Psychiatry. 1993. 8 (suppl 2):117S-124S